TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Valeant Pharmaceuticals International Board Under Investigation for Accepting the Biovail Offer

  • If you currently hold shares of Valeant Pharmaceuticals International (NYSE:VRX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

After the Valeant Pharmaceuticals board of directors announced the proposal by Biovail to merge with Valeant Pharmaceuticals Intl. several investigations on behalf of current investors Valeant Pharmaceuticals International (NYSE:VRX) over possible breaches of fiduciary duty by the board of directors of Valeant Pharmaceuticals was announced. The investigation by a law firm focuses on ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: